Dr. Jared Christian Inman, MD

Dr. Inman practices at Loma Linda University ENT/Head & Neck Surgery in Riverside, California.

Dr. Inman's NPI, 1841468063, was assigned on February 11, 2008. Dr. Inman graduated from Loma Linda University School Of Medicine in 2004. Dr. Inman's California license number on file is A94766.

Dr. Inman's primary practice is Loma Linda University ENT/Head & Neck Surgery, at 4646 Brockton Ave, Riverside, CA 92506 in Riverside County. The practice phone is (909) 558-3111.

Dr. Inman's primary practice is Loma Linda University ENT/Head & Neck Surgery in Riverside, California. Dr. Inman is also affiliated with Riverside Community Hospital. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Dr. Inman to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Inman practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Inman's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Inman is board certified in md by the American Board of Facial Plastic & Reconstructive Surgery. Dmand AI has Dr. Inman's licenses on file in 3 states: California, Arizona and Texas.

Dmand AI lists acute sinusitis, chronic sinusitis, endoscopic sinus surgery, larynx and vocal cord disease and thyroid surgery among the conditions Dr. Inman treats.

CMS data shows 421 Medicare services from Dr. Inman across 11 procedure codes in 2024, for 254 Medicare patients. Medicare paid $66,436 for them.

CMS counts 254 Medicare patients who saw Dr. Inman in 2024. The largest group is 65 to 74, with 115 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 41% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Inman's median patient age at 60, with 53% women.

In 2024, Dr. Inman wrote 237 Medicare Part D claims for 101 patients. 97% of them were for generic drugs. CMS names the drug for 130 of them, across 8 drugs with 11 or more claims each, at $1,262 in total drug cost. In 2023, CMS named 69 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Inman for performance year 2024, reported as part of a group. Dr. Inman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Inman as offering telehealth. CMS counts 36 procedures of melanoma (skin cancer) excision by Dr. Inman, more than 83% of the clinicians it reports for that procedure.

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 74 papers to Dr. Inman, published from 2010 to 2025. 2016 was the busiest year, with 10. The most frequent topics are Head and Neck Neoplasms, Plastic Surgery Procedures and Cadaver. Dr. Inman has published most often in Laryngoscope. Dr. Inman's most frequent co-authors are Yadranko Ducic, MD, Yuan F. Liu, MD and Ethan D. Frank, MD.

Dmand AI links Dr. Inman to 1 clinical trial. Conditions studied include Pain, Postoperative and Postoperative Complications.

CMS Open Payments shows 3 general payments to Dr. Inman from 2 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Stryker Corporation paid the most, $170.

Dr. Inman graduated from Loma Linda University School Of Medicine in 2004. Dr. Inman is a member of AAFPRS, NHS and ACS.

Dr. Inman is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.